Technology | June 16, 2009

Discovery PET/CT 690 for Exploration

Discovery PET/CT 600

As Discovery PET/CT 600 series continues to expand, GE Healthcare introduced the Discovery PET/CT 690 – a molecular imaging tool designed go beyond the needs of the clinical practice and provide the necessary tools and technologies to explore the future of PET/CT imaging.

The Discovery PET/CT 690 was built with the academic in mind. The breakthrough scanner allows for improved quantitative accuracy and the reconstruction power needed to explore the potential of PET/CT imaging. The new system leverages the high-speed, high-resolution capabilities of GE’s LightSpeed VCT. Combining the innovative molecular imaging platform with GE’s advanced volume CT and Discovery Dimension console technologies, the Discovery PET/CT 690 provides users with answers to flexibility, time, accuracy and motion.

With a unique detector configuration designed for sensitivity and efficiency, researchers and clinicians have the necessary speed in workflow and protocol flexibility to help explore new frontiers in clinical techniques, drug discovery and motion management.

The Discovery PET/CT 690 includes the exclusive IBM BladeCenter, where users have the ability to reconstruct PET images in minutes instead of hours, potentially improving workflow of detailed studies.

GE’s breakthrough VUE Point FX, the next generation in high-definition reconstruction, provides state of the art performance and unique timing resolution stability.

Like all of the Discovery PET/CT 600 Series products, he 690 incorporates MotionFree imaging technologies into the clinical workflow. This technology has the potential to improve small lesion detection and image quality when coupled with MotionFree techniques, especially in areas affected by patient motion. Leveraging the coincidence timing capabilities of the Discovery PET/CT 690, VUE Point FX incorporates time-of-flight acquisitions into the VUE Point HD 3D iterative process, providing for image quality improvements in PET/CT scan modes.

With the Discovery PET/CT 690, imagers can take advantage of advanced reconstruction and motion techniques at a routine pace. GE's next generation of MotionFree imaging technologies on the new Discovery PET/CT 690 are designed to give clinicians detailed images even in areas of the body subject to movement caused by respiration and cardiac movement. The scanner’s techniques address motion challenges including artifacts, blurring and quantification. With the MotionFree suite components, Motion Match to align the PET and CT gated studies, and Motion VUE to improve the reading of motion studies, motion management can be incorporated in research protocols. Users now have the ability to further diagnose and stage with accuracy, plan with precision and monitor with confidence.

With specialized detector configuration designed for sensitivity, event throughput and efficiency, researchers and clinicians have the necessary speed in workflow, protocol flexibility and unique timing resolution technology to help forge new frontiers in clinical techniques, drug discovery and motion management.

The Discover PET/CT 690 was released in 2009.

For more information: www.gehealthcare.com

Related Content

PET/CT, calcium blockages, heart attack risk, Intermountain study, American Heart Association, AHA Scientific Sessions 2016
News | PET-CT| November 15, 2016
Many people who experience chest pain but don’t have a heart attack breathe a big sigh of relief when a stress test...
PET/CT, atherosclerotic plaque detection, Stanford University

Application of dual-modality optical and PET/CT activity-based probe in experimental carotid inflammation model. Coronal noninvasive PET/CT scans of (A) healthy and (B) diseased mice with and without ligated carotid arteries respectively. Inset images show optical ex vivo florescence imagining of (A) healthy and (B) diseased carotid arteries.  PET/CT and optical images courtesy of Xiaowei Ma, Toshinobu Saito and Nimali Withana.

News | PET-CT| November 01, 2016
Researchers at Stanford University have demonstrated for the first time the use of a dual optical and positron emission...
GE Healthcare, Discovery MI PET/CT system, FDA clearance, RSNA 2016
Technology | PET-CT| October 05, 2016
GE Healthcare recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery MI digital...
Philips, SNMMI 2016, Vereos digital PET/CT, time-of-flight, IntelliSpace 8.0, nuclear imaging
News | Nuclear Imaging| June 14, 2016
Philips announced it would be showcasing a variety of nuclear imaging solutions at the Society of Nuclear Medicine and...
cardiac PET, myocardial perfusion, PET-CT, cardiac perfusion

A PET-CT cardiac perfusion exam from a Siemens Biograph scanner. The black and white areas of the image show the CT imaging of the anatomy. The colored portion shows the PET overlay on the myocardium and is color-coded to show tracer uptake values. This can show areas of the heart muscle where there are perfusion defects cause by infarcts or coronary artery blockages due to a heart attack and help determine the severity of the ischemia.

Feature | PET Imaging| June 03, 2016 | Dave Fornell
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enabl
PET/CT scan, brain stress center, heart disease predictor, ACC.16
News | PET-CT| April 05, 2016
New research shows individuals with a greater degree of activity in the stress center of the brain also have more...
Siemens, Biograph Horizon PET CT, FDA clearance
Technology | PET-CT| January 21, 2016
Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Biograph...
GE Healthcare, molecular imaging, PET/CT, Discovery IQ, Discovery NM/CT 670 Pro, RSNA 2015

Discovery IQ PET/CT scanner image courtesy of GE Healthcare

News | Nuclear Imaging| November 16, 2015
GE Healthcare’s Molecular Imaging business will showcase the Discovery IQ positron emission tomography/computed...
Toshiba, Celesteion, Steinberg Diagnostic Medical Imaging, U.S., first
News | PET-CT| June 08, 2015
Steinberg Diagnostic Medical Imaging (SDMI) of Las Vegas has bolstered its capabilities by installing the United...
Lantheus, flurpiridaz F 18, ICNC12, SPECT, CAD, PET, MPI, myocardial perfusion
News | May 04, 2015
Results from Lantheus Medical Imaging Inc.’s first Phase 3 study of flurpiridaz F 18 for myocardial perfusion imaging (...
Overlay Init